Bryan Fuller

Bryan Fuller is a cell and molecular biologist specializing in molecular endocrinology and skin research. He is the Founder and CEO of DermaMedics, a biopharmaceutical company developing novel non-steroidal dermatologic treatments.12

Professional Background:

• Received his B.S. from the University of Michigan and Ph.D. in Cell Biology and Biochemistry from the University of Arizona12
• Served as a Biochemistry and Molecular Biology Professor at the University of Oklahoma Health Sciences Center from 1985 to 20061
• Founded Therametics in 2006, a skin care product company, which was later sold to DermaMedics in 20121

Research Expertise: Dr. Fuller has over 25 years of research experience focusing on:

• Human skin pigmentation
• Hormonal regulation of skin melanocytes
• Inflammatory skin conditions
• Identifying botanically-derived chemicals for topical therapeutics2

Achievements:

• Issued 11 U.S. patents and 5 additional patent applications related to skin research2
• Created DermaMedics to develop pharmaceutical-quality skin care products using advanced molecular biology techniques2

His professional goal is to build DermaMedics into an internationally recognized company producing innovative, scientifically-developed skin care solutions that effectively address inflammation and skin aging.2